Benjamin F. Edwards & Company’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $3.13M | Buy |
2,980
+612
| +26% | +$643K | 0.06% | 292 |
|
|
2024
Q1 | $2.28M | Buy |
2,368
+807
| +52% | +$777K | 0.04% | 343 |
|
|
2023
Q4 | $1.37M | Buy |
1,561
+322
| +26% | +$283K | 0.03% | 420 |
|
|
2023
Q3 | $1.02M | Buy |
1,239
+1,178
| +1,931% | +$970K | 0.04% | 367 |
|
|
2023
Q2 | $44K | Buy |
61
+58
| +1,933% | +$41.8K | ﹤0.01% | 1124 |
|
|
2023
Q1 | $2K | Hold |
3
| – | – | ﹤0.01% | 1687 |
|
|
2022
Q4 | $2K | Sell |
3
-120
| -98% | -$80K | ﹤0.01% | 1742 |
|
|
2022
Q3 | $85K | Sell |
123
-11
| -8% | -$7.6K | ﹤0.01% | 908 |
|
|
2022
Q2 | $79K | Sell |
134
-101
| -43% | -$59.5K | ﹤0.01% | 933 |
|
|
2022
Q1 | $164K | Sell |
235
-20
| -8% | -$14K | 0.01% | 738 |
|
|
2021
Q4 | $161K | Buy |
255
+30
| +13% | +$18.9K | 0.01% | 752 |
|
|
2021
Q3 | $136K | Buy |
225
+33
| +17% | +$19.9K | 0.01% | 780 |
|
|
2021
Q2 | $107K | Sell |
192
-168
| -47% | -$93.6K | 0.01% | 829 |
|
|
2021
Q1 | $170K | Buy |
360
+37
| +11% | +$17.5K | 0.01% | 716 |
|
|
2020
Q4 | $156K | Buy |
323
+112
| +53% | +$54.1K | 0.01% | 706 |
|
|
2020
Q3 | $118K | Sell |
211
-462
| -69% | -$258K | 0.01% | 705 |
|
|
2020
Q2 | $420K | Buy |
673
+532
| +377% | +$332K | 0.03% | 404 |
|
|
2020
Q1 | $69K | Sell |
141
-53
| -27% | -$25.9K | 0.01% | 786 |
|
|
2019
Q4 | $73K | Sell |
194
-562
| -74% | -$211K | 0.01% | 871 |
|
|
2019
Q3 | $210K | Buy |
756
+731
| +2,924% | +$203K | 0.02% | 548 |
|
|
2019
Q2 | $8K | Hold |
25
| – | – | ﹤0.01% | 1497 |
|
|
2019
Q1 | $10K | Hold |
25
| – | – | ﹤0.01% | 1323 |
|
|
2018
Q4 | $9K | Buy |
+25
| New | +$9K | ﹤0.01% | 1315 |
|
|
2018
Q2 | – | Sell |
-50
| Closed | -$17K | – | 1634 |
|
|
2018
Q1 | $17K | Hold |
50
| – | – | ﹤0.01% | 1115 |
|
|
2017
Q4 | $19K | Buy |
+50
| New | +$19K | ﹤0.01% | 1040 |
|
|
2014
Q1 | – | Sell |
-8
| Closed | -$2K | – | 951 |
|
|
2013
Q4 | $2K | Buy |
+8
| New | +$2K | ﹤0.01% | 881 |
|